ImmunityBio drug trial date notes:

• Not included: trials with a status of withdrawn, terminated, unknown, or completed 2+ years ago.
• Trial date range starts with the primary study completion date ends with the study completion published on clinicaltrials.gov.
• For the timeline's readability and usability reasons, the smallest increment between the primary and study completion date is 10 days. There are a few cases where those dates are identical on clinicaltrials.gov.
• IBRX completes and withdraws studies without announcement, so there's no way to know if/when results are forthcoming. They also occasionally release preliminary data prior to study completion.
• I've only included trials ended after 2022.
• Reporting requirement for National Cancer Institute-sponsored studies: Within 12 months of the earlier of estimated/actual primary completion date.
• Drugs may have multiple names. For example: Anktiva = N-803 = Alt-803 = Inbakicept